Assessment of Patients Not Concluded After Neonatal Screening of Cystic Fibrosis.

ConditionCFTR-RD
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorHôpital Necker-Enfants Malades

About this trial

Assessment of the outcome of patients not concluded fir cystic fibrosis, either symptomatic patients or asymptomatic children detected by newborn screening for cystic fibrosis. The aim is to identify patients potentially at risk of progressing to the clinical spectrum of cystic fibrosis

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

patients carrying 2 CF causing variants of the CFTR gene

patients carrying only 1 or no variants of CFTR

Trial population

children of adults not concluded for the diagnosis of Cystic fibrosis

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

  • data collection

    Other intervention

    collection of data of generated by "real world" follow up

Treatment groups

400 Participants
are divided into 1 treatment group
Group A: patients with unconcluded diagnosis for cystic fibrosis1 intervention

Trial outcomes

Primary outcomes

1

lung Imaging

abnormal lung Imaging score, assessing the area of the lung with bronchiectasis, bronchial wall thickening, mucus plug and air trapping

Time frame
within 3 months after visit

Secondary outcomes

1

lung infection

sputum bacterial colonization (number of Colony Forming Unit) of bacteria, fungi

Time frame
within 2 weeks after visit
2

pancreatic function

fecal elastase in µg/g of feces

Time frame
within 2 weeks after visit

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: